Endologix develops vascular medical devices to treat abdominal aortic aneurysms (AAA) and peripheral artery disease (PAD). It sells advanced graft systems used inside blood vessels to repair weakened arteries and improve blood flow. Its products, such as AFX, Ovation, and ALTO, are designed to fit and work with a patient's own artery anatomy to provide durable, stable repairs and preserve the natural bifurcation of the vessels. The company differentiates itself through a focus on preserving native vascular anatomy, offering personalized repair options, and pursuing ongoing clinical excellence and product refinement. Its goal is to help healthcare professionals deliver better outcomes for patients with vascular conditions by providing reliable, long-lasting devices that address unmet needs in vascular care.
Company Size
501-1,000
Company Stage
IPO
Headquarters
Santa Rosa, California
Founded
1992
See people who can refer or advise you
Help us improve and share your feedback! Did you find this helpful?